Biomere and JOINN Labs announce the merger of a new premier, global nonclinical CRO with broad capabilities and experience in supporting gene therapy. With locations in the USA and China, we are ideally suited to help our clients advance their novel therapies
from early discovery through development.
Lonza provides contract development and manufacturing services that enable pharma and biotech companies to deliver medicines to patients. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of therapies. Together, let’s bring the next medicine to life.